fbpx Randomised double-blind placebo-controlled study of lisdexamfetamine for the treatment of methamphetamine dependence | NDARC - National Drug and Alcohol Research Centre
  1. Home
  2. Projects
  3. Randomised double-blind placebo-controlled study of lisdexamfetamine for the...

Randomised double-blind placebo-controlled study of lisdexamfetamine for the treatment of methamphetamine dependence

image - Lisdexamfetamine
Project Supporters:

NHMRC Project Grant

Project Members: 
image - Ndarc 153
Professor Kate Dolan
Adjunct Professor
Ph 02 9385 0333
image - Michael Farrell 0
Professor Michael Farrell
Director
Ph EA Tori Barnes: 02 9385 0292 / t.barnes@unsw.edu.au
Project Main Description: 

This randomised double-blind placebo-controlled study, led by St Vincent's Hospital Sydney, aims to examine the safety and efficacy of lisdexamfetamine in the treatment of adults with severe methamphetamine (MA) dependence.

Project Collaborators: External: 

Associate Professor Nadine Ezard (lead investigator)
St Vincents & Mater Health Sydney

Associate Professor Nicholas Lintzeris
University of Sydney

Associate Professor Robert Ali
The University of Adelaide

Professor Jason White
University of South Australia

Associate Professor Rebecca McKetin
Australian National University

James Ward
South Australian Health and Medical Research Institute in Adelaide

Mark Montebello
South Eastern Sydney Local Health District Drug and Alcohol Service